Inactive Instrument

APRIA

APR

US03836A1016

Apria, Inc. Provides Earnings Guidance for the Second Quarter of 2021

May 13, 2021 at 04:05 pm

Apria, Inc. provided earnings guidance for the second quarter of 2021. For the second quarter the company expected Net revenue of $277 million to $283 million.

Latest news about APRIA

Apria, Inc.(NasdaqGS:APR) dropped from S&P Global BMI Index	22-03-30	CI
Apria, Inc.(NasdaqGS:APR) dropped from S&P TMI Index	22-03-30	CI
Apria, Inc. Announces Management Changes	22-03-29	CI
Apria, Inc.(NasdaqGS:APR) dropped from NASDAQ Composite Index	22-03-29	CI
Byram Healthcare Centers, Inc. completed the acquisition of Apria, Inc. from Blackstone Inc. (NYSE:BX), John G. Figueroa and Daniel J. Starck and others.	22-03-28	CI
Owens & Minor Prices Upsized $600 Million Placement of 6.625% Notes Due 2030 for Apria Acquisition	22-03-23	MT
Owens & Minor to Raise $500 Million via Private Offering of Senior Notes	22-03-18	MT
Insider Sell: Apria	22-03-03	MT
Apria, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-28	CI
Earnings Flash (APR) APRIA Reports Q4 Revenue $296.5M	22-02-28	MT
North American Morning Briefing: All Eyes on -2-	22-01-12	DJ
S&P Revises Owens & Minor Outlook To Stable From Positive On Acquisition Of Apria Health, Ratings Affirmed	22-01-11	MT
UBS Downgrades Apria to Neutral From Buy, Adjusts Price Target to $37.50 From $41	22-01-11	MT
Top Midday Gainers	22-01-10	MT
Owens & Minor Eyes Diversified Revenue Stream With $1.6 Billion Takeover Deal for Healthcare Services Provider Apria	22-01-10	MT
Wall Street Set for Lower Open, Tech Rout Drags Nasdaq	22-01-10	MT
Health Care Stocks Slip Premarket Monday	22-01-10	MT
Health Care	22-01-10	MT
Top Premarket Gainers	22-01-10	MT
Owens & Minor to buy home healthcare provider Apria for $1.45 bln	22-01-10	RE
Owens & Minor to Acquire Apria in $1.6 Billion Deal	22-01-10	MT
Owens & Minor to buy Apria for about $1.45 bln	22-01-10	RE
Byram Healthcare Centers, Inc. entered into an agreement to acquire Apria, Inc. from Blackstone Inc. (NYSE:BX), John G. Figueroa and Daniel J. Starck and others for $1.4 billion.	22-01-09	CI
Certain Common Stock of Apria, Inc. are subject to a Lock-Up Agreement Ending on 9-JAN-2022.	22-01-08	CI
Certain Stock Appreciation Rights of Apria, Inc. are subject to a Lock-Up Agreement Ending on 9-JAN-2022.	22-01-08	CI

Apria, Inc. is a provider of integrated home healthcare equipment and related services in the United States. The Company offers a range of products and services for in-home care and delivery across three core service lines, which includes home respiratory therapy (including home oxygen and non-invasive ventilation (NIV) services); obstructive sleep apnea (OSA) treatment (including continuous positive airway pressure (CPAP) and bi-level positive airway pressure devices, and patient support services) and negative pressure wound therapy (NPWT). Additionally, the Company supplies a range of home medical equipment and other products and services for patients with home care needs. It also provides a variety of clinical and administrative support services and related products and supplies. It offers in-home delivery, set-up, and maintenance of equipment and/or supplies; monitoring therapy compliance and intervening to enhance compliance and processing claims to payors on behalf of patients.

Sector

More about the company

APRIA

Equities

APR

US03836A1016

Apria, Inc. Provides Earnings Guidance for the Second Quarter of 2021

Latest news about APRIA

Chart APRIA

Company Profile